Pharma Pricing and Reimbursement Strategies: The Impact of RWE
The integration of Real-World Evidence (RWE) into healthcare decision-making is transforming how pharmaceutical companies approach Health Economics and Outcomes Research (HEOR), pricing, and reimbursement strategies. To delve into these advancements, the EVIDENCE 360: Real World Evidence, Pricing & Reimbursement Summit Europe is scheduled for 26th-27th May 2025 in Frankfurt, Germany.
Summit...
0 Comments
0 Shares